Invivyd Financials
Invivyd (IVVD) reported $53.4M in revenue for fiscal year 2025, up 110.5% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Commercialization improved sharply, but the business still runs on fresh equity capital rather than internally generated cash.
From FY2024 to FY2025, revenue a little more than doubled while net loss fell by about two-thirds, but the more important shift was R&D dropping from$137.3M to$38.3M ; the economics improved because the company changed its spending posture as much as because it sold more. That progress also showed up in cash terms, because operating cash flow stayed close to net loss in both years, so the smaller loss came with a smaller cash drain rather than an accounting-only benefit.
FY2025 left the company much more liquid: cash rose to
Capital intensity is low at the fixed-asset level: free cash flow at
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Invivyd's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Invivyd's reported operating margin for fiscal year 2025 is below the lowest share of revenue this page publishes, so the figure is not shown here. This dimension scores 16/100.
Invivyd's revenue surged 110.5% year-over-year to $53.4M, reflecting rapid business expansion. This strong growth earns a score of 98/100.
Invivyd carries a low D/E ratio of 0.15, meaning only $0.15 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 78/100, indicating a strong balance sheet with room for future borrowing.
With a current ratio of 7.24, Invivyd holds $7.24 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 94/100.
Invivyd's reported free cash flow margin for fiscal year 2025 is below the lowest share of revenue this page publishes, so the figure is not shown here. This dimension scores 4/100.
Invivyd posts a -21.7% return on equity (ROE), meaning it loses $22 for every $100 of shareholders' equity. This results in a returns score of 14/100. This is up from -251.6% the prior year.
Invivyd scores 0.62, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($293.7M) relative to total liabilities ($35.3M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Invivyd passes 2 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 1 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.
Invivyd reported a net loss of $52.5M while operations used $58.1M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Key Financial Metrics
Earnings & Revenue
Invivyd generated $53.4M in revenue in fiscal year 2025. This represents an increase of 110.5% from the prior year.
Invivyd reported -$52.5M in net income in fiscal year 2025. This represents an increase of 69.1% from the prior year.
Not reported for fiscal year 2025.
Cash & Balance Sheet
Invivyd recorded an outflow of $58.3M in free cash flow in fiscal year 2025, representing a cash shortfall after capex. This represents an increase of 65.8% from the prior year.
Invivyd held $226.7M in cash as of fiscal year 2025; long-term debt is not reported for that period.
Not reported for fiscal year 2025.
Margins & Returns
Invivyd's net profit margin was -98.3% in fiscal year 2025, showing the share of revenue converted to profit. No change is given against fiscal year 2024: its reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Invivyd's ROE was -21.7% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 229.9 percentage points from the prior year.
Not reported for fiscal year 2025.
Not shown for fiscal year 2025: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Capital Allocation
Invivyd invested $38.3M in research and development in fiscal year 2025. This represents a decrease of 72.1% from the prior year.
Invivyd invested $155K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 10.7% from the prior year.
Not reported for fiscal year 2025.
IVVD Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY21 |
|---|---|---|---|---|---|---|---|
| Revenue | $58.4M | $53.4M+110.5% | $25.4M | $0 | N/A | N/A | N/A |
| R&D Expenses | $78.2M | $38.3M-72.1% | $137.3M-13.5% | $158.7M-11.5% | $179.2M-2.0% | $182.9M | N/A |
| SG&A Expenses | $88.2M | $66.9M+5.6% | $63.4M+29.0% | $49.1M+4.4% | $47.0M+28.8% | $36.5M | N/A |
| Operating Income | -$112.5M | -$55.6M+68.6% | -$176.9M+16.9% | -$212.8M+14.2% | -$248.0M-9.3% | -$226.9M | N/A |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | N/A |
| Net Income | -$107.3M | -$52.5M+69.1% | -$169.9M+14.5% | -$198.6M+17.7% | -$241.3M-6.4% | -$226.8M | -$38.7M |
| EPS (Diluted) | — | -$0.30 | -$1.43+21.0% | -$1.81+18.8% | -$2.23 | -$5.32 | N/A |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, Interest Expense.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
IVVD Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY21 |
|---|---|---|---|---|---|---|
| Total Assets | $276.9M+113.8% | $129.5M-43.5% | $229.2M-40.2% | $383.2M-38.2% | $620.1M | N/A |
| Current Assets | $247.5M+145.8% | $100.7M-55.2% | $224.9M-40.3% | $376.9M-38.9% | $616.7M | N/A |
| Cash & Equivalents | $226.7M+226.9% | $69.3M-65.4% | $200.6M+117.9% | $92.1M-83.0% | $542.2M | $91.2M |
| Inventory | $4.7M-81.7% | $25.9M | $0 | N/A | N/A | N/A |
| Accounts Receivable | $13.9M+27.6% | $10.9M | $0 | N/A | N/A | N/A |
| Total Liabilities | $35.3M-43.0% | $62.0M+19.8% | $51.7M+90.1% | $27.2M-56.2% | $62.1M | N/A |
| Current Liabilities | $34.2M-44.9% | $62.0M+23.2% | $50.3M+100.9% | $25.0M-59.7% | $62.1M | N/A |
| Total Equity | $241.5M+257.6% | $67.5M-61.9% | $177.5M-50.1% | $356.0M-36.2% | $558.0M | -$103.4M |
| Retained Earnings | -$954.5M-5.8% | -$902.0M-23.2% | -$732.1M-37.2% | -$533.4M-82.6% | -$292.1M | N/A |
Not reported in any period shown, so not listed: Goodwill, Long-Term Debt.
IVVD Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY21 |
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$108.4M | -$58.1M+65.9% | -$170.5M+1.5% | -$173.2M+21.3% | -$220.0M-19.1% | -$184.7M | N/A |
| Capital Expenditures | $1.2M | $155K+10.7% | $140K-77.2% | $615K-63.9% | $1.7M+1929.8% | $84K | N/A |
| Free Cash Flow | -$109.7M | -$58.3M+65.8% | -$170.6M+1.8% | -$173.8M+21.6% | -$221.7M-20.0% | -$184.8M | N/A |
| Investing Cash Flow | -$1.2M | -$155K-10.7% | -$140K-100.0% | $280.7M+221.7% | -$230.7M-354.9% | -$50.7M | N/A |
| Financing Cash Flow | $234.8M | $215.6M+448.2% | $39.3M+3663.7% | $1.0M+106.5% | $506K-99.9% | $662.7M | N/A |
| Share Buybacks | N/A | N/A | $0-100.0% | $1K-75.0% | $4K | $0 | N/A |
Not reported in any period shown, so not listed: Dividends Paid.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
IVVD Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY21 |
|---|---|---|---|---|---|---|
| Operating Margin | -104.0% | -696.8% | N/A | N/A | N/A | N/A |
| Net Margin | -98.3% | -669.4% | N/A | N/A | N/A | N/A |
| Return on Equity | -21.7%+229.9pp | -251.6%-139.7pp | -111.9%-44.1pp | -67.8%-27.1pp | -40.6% | N/A |
| Return on Assets | -19.0%+112.2pp | -131.2%-44.5pp | -86.7%-23.7pp | -63.0%-26.4pp | -36.6% | N/A |
| Current Ratio | 7.24+5.6x | 1.62-2.8x | 4.47-10.6x | 15.06+5.1x | 9.94 | N/A |
| Debt-to-Equity | 0.15-0.8x | 0.92+0.6x | 0.29+0.2x | 0.080.0x | 0.11 | N/A |
| FCF Margin | -109.1% | -672.2% | N/A | N/A | N/A | N/A |
Not reported in any period shown, so not listed: Gross Margin.
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.
Similar Companies
Where Invivyd Ranks
Frequently Asked Questions
What is Invivyd's annual revenue?
Invivyd (IVVD) reported $53.4M in total revenue for fiscal year 2025. This represents a 110.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Invivyd's revenue growing?
Invivyd (IVVD) revenue grew by 110.5% year-over-year, from $25.4M to $53.4M in fiscal year 2025.
Is Invivyd profitable?
No, Invivyd (IVVD) reported a net income of -$52.5M in fiscal year 2025, with a net profit margin of -98.3%.
What is Invivyd's net profit margin?
Invivyd (IVVD) had a net profit margin of -98.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Invivyd's return on equity (ROE)?
Invivyd (IVVD) has a return on equity of -21.7% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Invivyd's free cash flow?
Invivyd (IVVD) recorded an outflow of $58.3M in free cash flow during fiscal year 2025. This represents a 65.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Invivyd's operating cash flow?
Invivyd (IVVD) recorded an outflow of $58.1M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are Invivyd's total assets?
Invivyd (IVVD) had $276.9M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Invivyd's capital expenditures?
Invivyd (IVVD) invested $155K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Invivyd spend on research and development?
Invivyd (IVVD) invested $38.3M in research and development during fiscal year 2025.
What is Invivyd's current ratio?
Invivyd (IVVD) had a current ratio of 7.24 as of fiscal year 2025, which is generally considered healthy.
What is Invivyd's debt-to-equity ratio?
Invivyd (IVVD) had a debt-to-equity ratio of 0.15 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Invivyd's return on assets (ROA)?
Invivyd (IVVD) had a return on assets of -19.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Invivyd's cash runway?
Based on fiscal year 2025 data, Invivyd (IVVD) had $226.7M in cash against an annual operating cash burn of $58.1M. This gives an estimated cash runway of approximately 47 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
What is Invivyd's Altman Z-Score?
Invivyd (IVVD) has an Altman Z-Score of 0.62, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Invivyd's Piotroski F-Score?
Invivyd (IVVD) has a Piotroski F-Score of 2 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Invivyd's earnings high quality?
Invivyd (IVVD) reported a net loss of $52.5M while operations used $58.1M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Invivyd?
Invivyd (IVVD) scores 51 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.